EDGAR Filing Documents for 0000903423-18-000274

Form SC 13D - General Statement of Acquisition of Beneficial Ownership:

SEC Accession No. 0000903423-18-000274

Filing Date

2018-05-14

Accepted

2018-05-14 16:26:17

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		amneal13d_0514.htm	SC 13D	75112
2		amneal13dex2_0514.htm	EX-2	296338
3		amneal13dex3_0514.htm	EX-3	7868
	Complete submission text file	0000903423-18-000274.txt		380856

Mailing Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102

Business Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102 817-871-4000

TPG Group Holdings (SBS) Advisors, Inc. (Filed by) CIK: 0001495741 (see all company filings)

IRS No.: 271650453 | State of Incorp.: DE
Type: SC 13D

Mailing Address C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE HAYWARD CA 94544

Business Address 510-240-6000

Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90473 | Film No.: 18831054
SIC: 2834 Pharmaceutical Preparations